Research graph
References from Interpretation of Changes in Circulating Tumor Cell Counts. Local targets link to admitted publications; unresolved targets remain external evidence.
Circulating melanoma cells and survival in metastatic melanoma
2011 · External reference
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
10.1056/nejmoa040766 · 2004 · External reference
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
10.1200/jco.2007.15.8923 · 2008 · External reference
Circulating tumor cells predict survival benefit from treatment in metastatic castrationresistant prostate cancer
10.1158/1078-0432.ccr-08-0872 · 2008 · External reference
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
10.1111/j.1349-7006.2010.01492.x · 2010 · External reference
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer
10.1200/jco.2010.28.7045 · 2011 · External reference
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
10.1093/annonc/mds138 · 2012 · External reference
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
10.1158/1078-0432.ccr-05-2821 · 2006 · External reference
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer
10.1158/1078-0432.ccr-05-1769 · 2006 · External reference
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
10.1093/annonc/mdp262 · 2010 · External reference
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases
10.1158/1078-0432.ccr-04-0378 · 2004 · External reference
Circulating tumour cells as prognostic markers in progressive, castrationresistant prostate cancer: a reanalysis of IMMC38 trial data
10.1016/s1470-2045(08)70340-1 · 2009 · External reference
Statistical considerations for enumeration of circulating tumor cells
10.1002/cyto.a.20369 · 2007 · External reference
Challenges in the enumeration and phenotyping of CTC
10.1158/1078-0432.ccr-12-1585 · 2012 · External reference
Circulating tumor cells (CTC) in newly diagnosed breast or colorectal cancer
2007 · External reference
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system
10.1158/1078-0432.ccr-06-1695 · 2007 · External reference
Evaluation of circulating tumor cells in patients with breast cancer: multiinstitutional clinical trial in Japan
10.1007/s10147-007-0748-9 · 2008 · External reference
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
10.1093/annonc/mdp391 · 2010 · External reference
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
10.1158/1078-0432.ccr-06-2701 · 2007 · External reference
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer
10.1200/jco.2008.20.6664 · 2009 · External reference
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial markerdependent and -independent approaches
10.1097/jto.0b013e31823c5c16 · 2012 · External reference
